欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0245/001
药品名称
Cevac IBird
活性成分
Infectious Bronchitis Virus 2.8 EID50/dose
剂型
Oral lyophilisate
上市许可持有人
CEVA Santé Animale
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Belgium (BE)
Cevac IBird
Netherlands (NL)
Hungary (HU)
Cevac IBird vakcina A.U.V.
Bulgaria (BG)
Cyprus (CY)
Sweden (SE)
Slovenia (SI)
Slovakia (SK)
Romania (RO)
Czechia (CZ)
Estonia (EE)
Cevac IBird
Lithuania (LT)
CEVAC IBird, liofilizatas geriamajai suspensijai ruošti viščiukams
Latvia (LV)
Cevac IBird
Poland (PL)
Cevac IBird lyophilisate for suspension for chickens
Greece (GR)
Italy (IT)
Portugal (PT)
Spain (ES)
Austria (AT)
Ireland (IE)
Cevac IBird
United Kingdom (Northern Ireland) (XI)
Luxembourg (LU)
Denmark (DK)
Cevac Ibird
Germany (DE)
CEVAC IBird
Finland (FI)
Malta (MT)
Croatia (HR)
许可日期
2013/05/29
最近更新日期
2024/06/10
药物ATC编码
QI IMMUNOLOGICALS
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Full dossier - art 12.3 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
13388_ Cevac IBird_ PuAR
Date of last change:2024/09/06
PubAR
|
13388_ Cevac IBird_ PuARrevised after WS022
Date of last change:2024/09/06
Final SPC
|
cevac_ibird_pi_D90_29032017
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase